{"name":"Sachin Desai","slug":"sachin-desai","ticker":"","exchange":"","domain":"","description":"Sachin Desai is a specialized pharmaceutical company focused on the development and commercialization of vaccines, particularly in the area of infectious diseases. The company has two marketed products, both oral cholera vaccines, which are crucial in preventing cholera outbreaks in endemic regions.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Shanchol™, oral cholera vaccine","genericName":"Shanchol™, oral cholera vaccine","slug":"shanchol-oral-cholera-vaccine","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Shanchol™, oral cholera vaccine","genericName":"Shanchol™, oral cholera vaccine","slug":"shanchol-oral-cholera-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNa25RVEM4bXlNRWVNSmRLdFM4bFl2TS1sQU9aN09iQk5MaENyVkNBSE5iQ2FyZGVuUGo1VzI0dnZyOHVtcW1XOXhObldwQ3RBMXZXV29MUVMtdGdGVlBRNlpCX09LbFZ2OU9LZDRMUk91RUtfS2tqcnJOQ1NfUzlzbDMxNUZ6QU1jMkRuNHhtbzdsaHFXbmN5MWlfMzZhZjZERjNmeGlXWmM4VV9iQmFSdk1sUGpSZw?oc=5","date":"2021-10-29","type":"pipeline","source":"Bloomberg Law News","summary":"Fusion Energy Firm Helion Looks to Hogan Lovells for Top Lawyer - Bloomberg Law News","headline":"Fusion Energy Firm Helion Looks to Hogan Lovells for Top Lawyer","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}